Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia

por Khasawneh, Fadi T., Shankar, Gollapudi S.
Publicado 2014

Positive and Negative Syndrome Scale as a long-term outcome measurement tool in patients receiving clozapine ODT- A Pilot Study

por Shankar, Gollapudi, Nate, Carmen
Publicado 2007

A retrospective cohort study of the prevalence of anxiety and agitation in schizophrenic smokers and the unmet needs of smoking cessation programs

por Hassanzadah, Mehgan, Bitar, Adib H, Khanfar, Nile M, Khasawneh, Fadi T, Lutfy, Kabirullah, Shankar, Gollapudi S
Publicado 2019